Delaware
|
001-16753
|
06-1500476
|
(State
or other Jurisdiction
of
Incorporation)
|
(Commission
File Number)
|
(I.R.S.
Employer
Identification
No.)
|
12400
High Bluff Drive, Suite 100
|
92130
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (866)
871-8519
|
Not
Applicable
(Former
name or former address, if changed from last
report)
|
¨
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
¨
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
¨
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
¨
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
AMN
Healthcare Services, Inc.
|
||
Date:
May 6, 2010
|
By:
|
/s/ Susan R.
Nowakowski
|
Susan
R. Nowakowski
|
||
President &
Chief Executive
Officer
|
Contact:
|
|
Amy
C. Chang
|
|
Vice
President, Investor Relations
|
|
866.861.3229
|
Q1
2010 |
% Chg
Q1 2009
|
%
Chg
Q4
2009
|
|||||||||
Revenue
|
$ | 143.3 | (43 | )% | (1 | )% | |||||
Gross
Profit
|
$ | 40.0 | (37 | )% | (3 | )% | |||||
Net
Income
|
$ | 0.8 |
NM
|
NM
|
|||||||
Diluted
Earnings per Share
|
$ | 0.02 |
NM
|
NM
|
|||||||
Cash
Flow from Operations
|
$ | 11.7 | (69 | )% | 110 | % | |||||
Adjusted
EBITDA*
|
$ | 10.4 | (37 | )% | (3 | )% |
|
·
|
Earnings
per share of $0.02 were above
expectations
|
|
·
|
Revenues
were sequentially stable
|
|
·
|
SG&A
expense continued to improve
|
|
·
|
Nurse
and Allied traveler count volume experienced a 5% sequential
increase
|
|
·
|
Locum
Tenens and Physician Permanent Placement volumes were sequentially
flat
|
Three
Months Ended
|
||||||||||||
March
31,
|
December
31,
|
|||||||||||
2010
|
2009
|
2009
|
||||||||||
Revenue
|
$ | 143,294 | $ | 249,595 | $ | 144,698 | ||||||
Cost
of revenue
|
103,250 | 185,612 | 103,545 | |||||||||
Gross
profit
|
40,044 | 63,983 | 41,153 | |||||||||
27.9 | % | 25.6 | % | 28.4 | % | |||||||
Expenses:
|
||||||||||||
Selling,
general and administrative
|
31,950 | 50,080 | 32,388 | |||||||||
22.3 | % | 20.1 | % | 22.4 | % | |||||||
Depreciation
and amortization
|
3,298 | 3,467 | 3,408 | |||||||||
Impairment
and restructuring charges
|
- | 178,625 | - | |||||||||
Total
operating expenses
|
35,248 | 232,172 | 35,796 | |||||||||
Income
(loss) from operations
|
4,796 | (168,189 | ) | 5,357 | ||||||||
3.3 | % | (67.4 | )% | 3.7 | % | |||||||
Interest
expense, net
|
2,637 | 2,199 | 5,373 | |||||||||
Income
(loss) before income taxes
|
2,159 | (170,388 | ) | (16 | ) | |||||||
Income
tax expense (benefit)
|
1,379 | (48,554 | ) | 2,706 | ||||||||
Net
income (loss)
|
$ | 780 | $ | (121,834 | ) | $ | (2,722 | ) | ||||
0.5 | % | (48.8 | )% | (1.9 | )% | |||||||
Net
income (loss) per common share:
|
||||||||||||
Basic
|
$ | 0.02 | $ | (3.74 | ) | $ | (0.08 | ) | ||||
Diluted
|
$ | 0.02 | $ | (3.74 | ) | $ | (0.08 | ) | ||||
Weighted
average common shares outstanding:
|
||||||||||||
Basic
|
32,631 | 32,576 | 32,631 | |||||||||
Diluted
|
33,471 | 32,576 | 32,631 |
Three
Months Ended
|
||||||||||||||||||||||||
March
31,
|
December
31
|
|||||||||||||||||||||||
2010
|
%
of
Rev
|
2009
|
%
of
Rev
|
2009
|
%
of
Rev
|
|||||||||||||||||||
Revenue
|
||||||||||||||||||||||||
Nurse
and allied healthcare staffing
|
$ | 75,191 | $ | 163,850 | $ | 73,999 | ||||||||||||||||||
Locum
tenens staffing
|
60,388 | 74,791 | 62,447 | |||||||||||||||||||||
Physician
permanent placement services
|
7,715 | 10,954 | 8,252 | |||||||||||||||||||||
$ | 143,294 | $ | 249,595 | $ | 144,698 | |||||||||||||||||||
Reconciliation
of Non-GAAP Items:
|
||||||||||||||||||||||||
Segment
Operating Income(1)
|
||||||||||||||||||||||||
Nurse
and allied healthcare staffing
|
$ | 8,734 | 11.6 | % | $ | 14,722 | 9.0 | % | $ | 7,686 | 10.4 | % | ||||||||||||
Locum
tenens staffing
|
5,471 | 9.1 | % | 4,653 | 6.2 | % | 6,459 | 10.3 | % | |||||||||||||||
Physician
permanent placement services
|
1,966 | 25.5 | % | 3,275 | 29.9 | % | 1,942 | 23.5 | % | |||||||||||||||
16,171 | 11.3 | % | 22,650 | 9.1 | % | 16,087 | 11.1 | % | ||||||||||||||||
Unallocated
corporate overhead
|
5,728 | 6,072 | 5,374 | |||||||||||||||||||||
Adjusted
EBITDA(2)
|
10,443 | 7.3 | % | 16,578 | 6.6 | % | 10,713 | 7.4 | % | |||||||||||||||
Depreciation
and amortization
|
3,298 | 3,467 | 3,408 | |||||||||||||||||||||
Stock-based
compensation
|
2,349 | 2,675 | 1,948 | |||||||||||||||||||||
Impairment
and restructuring charges
|
- | 178,625 | - | |||||||||||||||||||||
Interest
expense, net
|
2,637 | 2,199 | 5,373 | |||||||||||||||||||||
Income
(loss) before income taxes
|
2,159 | (170,388 | ) | (16 | ) | |||||||||||||||||||
Income
tax expense (benefit)
|
1,379 | (48,554 | ) | 2,706 | ||||||||||||||||||||
Net
income (loss)
|
$ | 780 | $ | (121,834 | ) | $ | (2,722 | ) |
Three
Months Ended
|
||||||||||||
March
31,
|
December
31,
|
|||||||||||
2010
|
2009
|
2009
|
||||||||||
Gross
Margin
|
||||||||||||
Nurse
and allied healthcare staffing
|
26.3 | % | 23.0 | % | 27.0 | % | ||||||
Locum
tenens staffing
|
26.2 | % | 26.2 | % | 26.0 | % | ||||||
Physician
permanent placement services
|
57.9 | % | 61.6 | % | 60.0 | % | ||||||
Operating Data:
|
||||||||||||
Nurse
and allied healthcare staffing
|
||||||||||||
Average
travelers on assignment (3)
|
2,505 | 5,489 | 2,396 | |||||||||
Revenue
per traveler per day (4)
|
$ | 333.51 | $ | 331.67 | $ | 335.70 | ||||||
Gross
profit per traveler per day (4)
|
$ | 87.68 | $ | 76.19 | $ | 90.52 | ||||||
Locum
tenens staffing
|
||||||||||||
Days
filled (5)
|
43,065 | 52,396 | 43,276 | |||||||||
Revenue
per day filled (5)
|
$ | 1,402 | $ | 1,427 | $ | 1,443 | ||||||
Gross
profit per day filled (5)
|
$ | 367.08 | $ | 374.02 | $ | 375.55 |
As of March 31,
|
As of December
31
|
|||||||||||
2010
|
2009
|
2009
|
||||||||||
Leverage
Ratio (6)
|
2.1 | 1.3 | 1.9 |
(1)
|
Segment
Operating Income represents net income (loss) plus interest expense (net
of interest income), income taxes, depreciation and amortization,
impairment and restructuring charges, unallocated corporate expenses, and
stock-based compensation expense. Management believes that Segment
Operating Income is an industry wide financial measure that is useful both
to management and investors when evaluating the company’s performance.
Management also uses Segment Operating Income for planning purposes.
Segment Operating Income is not necessarily comparable to other similarly
titled captions of other companies due to potential inconsistencies in the
method of calculation and allocation of
costs.
|
(2)
|
Adjusted
EBITDA represents net income (loss) plus interest expense (net of interest
income), income taxes, depreciation and amortization, impairment and
restructuring charges, and stock-based compensation expense. Management
presents adjusted EBITDA because it believes that adjusted EBITDA is a
useful supplement to net income as an indicator of operating performance.
Management believes that adjusted EBITDA is an industry wide financial
measure that is useful both to management and investors when evaluating
the company’s performance. Management also uses adjusted EBITDA for
planning purposes. Management uses adjusted EBITDA to evaluate the
company’s performance because it believes that adjusted EBITDA provides an
effective measure of the company’s results, as it excludes certain items
that management believes are not indicative of the company’s operating
performance and considers measures used in credit facilities. However,
adjusted EBITDA is not intended to represent cash flows for the period,
nor has it been presented as an alternative to income (loss) from
operations or net income (loss) as an indicator of operating performance,
and it should not be considered in isolation or as a substitute for
measures of performance prepared in accordance with GAAP. As defined,
adjusted EBITDA is not necessarily comparable to other similarly titled
captions of other companies due to potential inconsistencies in the method
of calculation. While management believes that some of the items excluded
from adjusted EBITDA are not indicative of the company’s operating
performance, these items do impact the income statement, and management
therefore utilizes adjusted EBITDA as an operating performance measure in
conjunction with GAAP measures such as net
income.
|
(3)
|
Average
travelers on assignment represents the average number of nurse and allied
healthcare professionals on assignment during the period
presented.
|
(4)
|
Revenue
per traveler per day and gross profit per traveler per day represent the
revenue and gross profit of the company’s nurse and allied healthcare
staffing segment divided by average travelers on assignment, divided by
the number of days in the period
presented.
|
(5)
|
Days
filled is calculated by dividing the locum tenens hours filled during the
period by 8 hours. Revenue per day filled and gross profit per day filled
represent revenue and gross profit of the company’s locum tenens staffing
segment divided by days filled for the period
presented.
|
(6)
|
Leverage
ratio represents the ratio of the total debt outstanding at the end of the
period to the Adjusted EBITDA for the past twelve
months.
|
March
31,
|
December
31,
|
|||||||
2010
|
2009
|
|||||||
Assets
|
||||||||
Current
assets:
|
||||||||
Cash
and cash equivalents
|
$ | 36,567 | $ | 27,053 | ||||
Accounts
receivable, net
|
89,085 | 89,498 | ||||||
Prepaid
expenses
|
7,152 | 6,550 | ||||||
Income
taxes receivable
|
2,735 | 3,900 | ||||||
Deferred
income taxes, net
|
8,534 | 8,534 | ||||||
Other
current assets
|
6,039 | 1,902 | ||||||
Total
current assets
|
150,112 | 137,437 | ||||||
Restricted
cash and cash equivalents
|
22,022 | 22,025 | ||||||
Fixed
assets, net
|
18,538 | 19,970 | ||||||
Deposits
and other assets
|
14,432 | 14,368 | ||||||
Goodwill
|
79,868 | 79,868 | ||||||
Intangible
assets, net
|
114,135 | 115,336 | ||||||
Total
assets
|
$ | 399,107 | $ | 389,004 | ||||
Liabilities
and stockholders’ equity
|
||||||||
Current
liabilities:
|
||||||||
Accounts
payable and accrued expenses
|
24,493 | 18,057 | ||||||
Accrued
compensation and benefits
|
28,178 | 24,054 | ||||||
Current
portion of notes payable
|
6,875 | 5,500 | ||||||
Deferred
revenue
|
5,158 | 5,084 | ||||||
Other
current liabilities
|
10,042 | 10,404 | ||||||
Total
current liabilities
|
74,746 | 63,099 | ||||||
Notes
payable, less current portion and discount
|
97,721 | 100,121 | ||||||
Deferred
income taxes, net
|
— | 789 | ||||||
Other
long-term liabilities
|
52,664 | 54,151 | ||||||
Total
liabilities
|
225,131 | 218,160 | ||||||
Stockholders’
equity
|
173,976 | 170,844 | ||||||
Total
liabilities and stockholders’ equity
|
$ | 399,107 | $ | 389,004 |
Three
Months Ended
|
||||||||||||
March
31,
|
December
31,
|
|||||||||||
2010
|
2009
|
2009
|
||||||||||
Net
cash provided by operating activities
|
$ | 11,715 | $ | 37,557 | $ | 5,582 | ||||||
Net
cash used in investing activities
|
(668 | ) | (1,230 | ) | (22,887 | ) | ||||||
Net
cash provided by (used in) financing activities
|
(1,536 | ) | (30,954 | ) | 21,721 | |||||||
Effect
of exchange rates on cash
|
3 | (14 | ) | 16 | ||||||||
Net
increase in cash and cash equivalents
|
9,514 | 5,359 | 4,432 | |||||||||
Cash
and cash equivalents at beginning of period
|
27,053 | 11,316 | 22,621 | |||||||||
Cash
and cash equivalents at end of period
|
$ | 36,567 | $ | 16,675 | $ | 27,053 |